COSMO PHARMACEUTICALS NV revenue for the last year amounted to 266.79 M EUR, the most of which — 192.78 M EUR — came from its highest performing source at the moment, Licence Fees, Up-front Fees and Milestones, the year earlier bringing 9.50 M EUR. The greatest contribution to the revenue figure was made by Italy — last year it brought COSMO PHARMACEUTICALS NV 270.31 M EUR, and the year before that — 97.00 M EUR.